Education
About Us
Working with TipRanks
Follow Us
ASKA Pharmaceutical Holdings Co., Ltd. (JP:4886)
:4886
4886 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥1,825.00 - ¥2,720.00
Previous CloseN/A
Volume48.10K
Average Volume (3M)N/A
Market Cap
¥64.35B
Enterprise Value¥56.79B
Total Cash (Recent Filing)¥7.90B
Total Debt (Recent Filing)¥16.43B
Price to Earnings (P/E)12.1
Beta0.68
Next Earnings
May 08, 2025EPS EstimateN/A
Next Dividend Ex-Date
Mar 28, 2025Dividend Yield2.03%
Share Statistics
EPS (TTM)182.94
Shares Outstanding30,563,198
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
ASKA Pharmaceutical Holdings Co., Ltd. News
PremiumCompany Announcements
ASKA Pharmaceutical to Cancel 1.8 Million Treasury Shares
PremiumCompany Announcements
ASKA Pharmaceutical Holdings Recognized for Health Management Excellence
PremiumCompany Announcements
ASKA Launches Clinical Trial for New Gynecological Drug in Japan
PremiumCompany Announcements
ASKA Pharmaceutical Announces Key Personnel Changes
PremiumCompany Announcements
ASKA Pharmaceutical Announces Key Organizational Changes
PremiumCompany Announcements
ASKA Pharmaceutical Achieves Record Sales Amidst Rising R&D Costs
PremiumCompany Announcements
ASKA Pharmaceutical Announces Third Quarter FY2024 Financial Results---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.26% Mutual Funds
― Other Institutional Investors
94.32% Public Companies and
Individual Investors
4886 FAQ
What was ASKA Pharmaceutical Holdings Co., Ltd.’s price range in the past 12 months?
ASKA Pharmaceutical Holdings Co., Ltd. lowest stock price was ¥1825.00 and its highest was ¥2720.00 in the past 12 months.
What is ASKA Pharmaceutical Holdings Co., Ltd.’s market cap?
ASKA Pharmaceutical Holdings Co., Ltd.’s market cap is ¥64.35B.
When is ASKA Pharmaceutical Holdings Co., Ltd.’s upcoming earnings report date?
ASKA Pharmaceutical Holdings Co., Ltd.’s upcoming earnings report date is May 08, 2025 which is in 56 days.
How were ASKA Pharmaceutical Holdings Co., Ltd.’s earnings last quarter?
ASKA Pharmaceutical Holdings Co., Ltd. released its earnings results on Feb 03, 2025. The company reported ¥54.23 earnings per share for the quarter, beating the consensus estimate of N/A by ¥54.23.
Is ASKA Pharmaceutical Holdings Co., Ltd. overvalued?
According to Wall Street analysts ASKA Pharmaceutical Holdings Co., Ltd.’s price is currently Overvalued.
Does ASKA Pharmaceutical Holdings Co., Ltd. pay dividends?
ASKA Pharmaceutical Holdings Co., Ltd. pays a Annually dividend of ¥25 which represents an annual dividend yield of 2.03%. See more information on ASKA Pharmaceutical Holdings Co., Ltd. dividends here
What is ASKA Pharmaceutical Holdings Co., Ltd.’s EPS estimate?
ASKA Pharmaceutical Holdings Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ASKA Pharmaceutical Holdings Co., Ltd. have?
ASKA Pharmaceutical Holdings Co., Ltd. has 30,563,198 shares outstanding.
What happened to ASKA Pharmaceutical Holdings Co., Ltd.’s price movement after its last earnings report?
ASKA Pharmaceutical Holdings Co., Ltd. reported an EPS of ¥54.23 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.965%.
Which hedge fund is a major shareholder of ASKA Pharmaceutical Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4886
---
Technical Analysis
Terumo
―
Chugai Pharmaceutical Co
―
Sumitomo Dainippon Pharma Co
―
Eisai Co
―
Takeda Pharmaceutical Co
―
---